Research output per year
Research output per year
Personal profile
Research interests
Cancer Research, Translational Science, Transcriptomics, Gene Regulation, Drug Development
Research interests
Dr. Eldhose is involved in basic science and translational research in prostate cancer towards the exploration of prostate cancer associated genes such as ERG and androgen regulated gene. His specific goals are to determine the key elements of prostate tumorigenesis and to develop new drugs for the precision treatment of prostate cancer. He specializes in drug development and has made important contributions in developing precision medicne towards ERG regulated prostate cancer.
Biography
Dr. Binil Eldhose is an Assistant Professor and a Scientist at the Henry M. Jackson Foundation for the Advancement of Military Medicine in support of the Murtha Cancer Center Research Program (MCCRP) and the Center for Prostate Disease Research (CPDR). Dr. Eldhose holds a Research Assistant Professor academic appointment at the Uniformed Services University (USU), F. Edward Hébert School of Medicine, in the USU-Walter Reed Department of Surgery.
Fingerprint
Dive into the research topics where Binil Eldhose is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Germline Mutations and Ancestry in Prostate Cancer
Bataba, E., Babcock, K., Isensee, K. A., Eldhose, B., Kohaar, I., Chesnut, G. T. & Dobi, A., Feb 2024, In: Current Oncology Reports. 26, 2, p. 175-180 6 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Emerging Developments in ETS-Positive Prostate Cancer Therapy: Corresponding author
Eldhose, B., 1 Feb 2023, In: Molecular Cancer Therapeutics. Mol Cancer Ther . 2023 Feb 1;22(2):168-178. doi: 10.1158/1535-7163.MCT-22-0527.Research output: Contribution to journal › Review article › peer-review
-
Emerging Developments in ETS-Positive Prostate Cancer Therapy
Bowling, G. C., Rands, M. G., Dobi, A. & Eldhose, B., 1 Feb 2023, In: Molecular Cancer Therapeutics. 22, 2, p. 168-178 11 p.Research output: Contribution to journal › Review article › peer-review
Open Access5 Scopus citations -
Hematological Toxicities with PARP Inhibitors in Prostate Cancer: A Systematic Review and Meta-Analysis of Phase II/III Randomized Controlled Trials
Bowling, G. C., Swargaloganathan, P., Heintz, C., Madan, R. A., Eldhose, B., Dobi, A. & Chesnut, G. T., Oct 2023, In: Cancers. 15, 19, 4904.Research output: Contribution to journal › Review article › peer-review
Open Access2 Scopus citations -
Role of phospholipase A2 in prostate cancer
Eldhose, B. & Wilson, C., 1 Jan 2023, Phospholipases in Physiology and Pathology: Volumes 1-7. Elsevier, Vol. 3. p. V3-39-V3-54Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review
Press/Media
-
New Findings on Prostate Cancer Described by Investigators at Uniformed Services University of the Health Sciences (Germline Mutations and Ancestry In Prostate Cancer)
Gregory Chesnut, Albert Dobi, Binil Eldhose & Indu Kohaar
19/02/24
1 item of Media coverage
Press/Media
-
HJF Supported Research Center Publishes Research Demonstrating a New Way to Fight Drug-Resistant Prostate Disease
20/01/22
1 item of Media coverage
Press/Media